CAR T-cell therapy – Discover Pharma

Welcome to Discover Pharma! Today is : June 13, 2026

CAR T-cell therapy

Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain
FDA clears IND amendment for automated manufacturing of Cabaletta’s rese-cel using Cellares platforms
Cellares has secured FDA clearance of an IND amendment allowing [...]

May 5, 2026
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain
Trenchant BioSystems confirms AutoCell platform can cut CGT manufacturing to 2.5 days
Trenchant BioSystems has released internal and external data confirming its [...]

May 5, 2026
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
CytoAgents receives fourth NIH grant to advance research on cytokine release syndrome in CAR T-cell therapy
CytoAgents, a clinical-stage biotechnology company developing an oral small-molecule immune [...]

May 5, 2026
Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics
BioGrad unveils state-of-the-art Liverpool bio-manufacturing centre to drive cell and gene therapy growth in the North
BioGrad has announced plans for a new Centre of Bio-Manufacturing [...]

May 5, 2026
Advanced Therapies,Opinion & Events
CAR T Vision coalition sets goal to double access to therapy by 2030
A new international alliance, CAR T Vision, launched today with [...]

May 5, 2026
Advanced Therapies,Clinical & Regulatory,Opinion & Events
Digital shift aims to fix long-term gaps in cell and gene therapy trials
Medable unveils a patient-first remote model to support 15-year safety [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK